부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Company news | Bukwang Pharm. activates its consumer health business encom..
Bukwang Pharmaceuticals Co., Ltd. (Co-presidents and CEOs Ms. Hee-Won Yoo, PhD. ..
2015.07.09
Company news | Employees of Bukwang Pharm. reap great benefits from shares ..
In August 2011, Bukwang Pharmaceuticals Co., Ltd. (Co-presidents and CEOs Ms. He..
2015.06.10
Company news | Bukwang Pharm. starts dosing in the first patient with JM-01..
Bukwang Pharm. and its fully owned subsidiary Contera Pharma are pleased to anno..
2015.06.08
Company news | Bukwang Pharm’s subsidiary Contera Pharma initiates Eurosta..
Contera Pharma, in collaboration with Solural Pharma Ernst Moritz Arndt Universi..
2015.05.21
R&D news | Bukwang Pharm’s LID candidate JM-010 receives IND approval f..
Bukwang Pharm. announced that it received IND approval for the Phase 2a clinical..
2015.04.27
Company news | Dr. Hee-Won Yoo appointed as co-president and CEO of Bukwan..
Bukwang Pharm. appointed Dr. Hee-Won Yoo as the co-president and CEO of the comp..
2015.03.20
16
17